Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2017, Article ID 2457023, 5 pages
https://doi.org/10.1155/2017/2457023
Case Report

Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy

1Department of Urology, Albertinen-Krankenhaus Hamburg, Süntelstrasse 11a, 22457 Hamburg, Germany
2Department of Diagnostic Radiology, Albertinen-Krankenhaus Hamburg, Süntelstrasse 11a, 22457 Hamburg, Germany
3Institute of Pathology, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany

Correspondence should be addressed to Klaus-Peter Dieckmann; ed.enilno-t@pknnamkceid

Received 15 January 2017; Accepted 27 February 2017; Published 7 March 2017

Academic Editor: Didier Frappaz

Copyright © 2017 Klaus-Peter Dieckmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. E. Howitt and D. M. Berney, “Tumors of the testis: morphologic features and molecular alterations,” Surgical Pathology Clinics, vol. 8, no. 4, pp. 687–716, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Moch, A. L. Cubilla, P. A. Humphrey, V. E. Reuter, and T. M. Ulbright, “The 2016 WHO classification of tumours of the urinary system and male genital organs—Part A: renal, penile, and testicular tumours,” European Urology, vol. 70, pp. 93–105, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. N. B. Friedman and R. A. Moore, “Tumors of the testis: a report on 922 cases,” Military Surgeon, vol. 99, pp. 573–593, 1946. View at Google Scholar
  4. G. Mikuz and M. Colecchia, “Teratoma with somatic-type malignant components of the testis. A review and an update,” Virchows Archiv, vol. 461, no. 1, pp. 27–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Motzer, A. Amsterdam, V. Prieto et al., “Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors,” Journal of Urology, vol. 159, no. 1, pp. 133–138, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Necchi, M. Colecchia, N. Nicolai et al., “Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal,” BJU International, vol. 107, no. 7, pp. 1088–1094, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Zeh, P. J. Wild, P. K. Bode et al., “Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy,” BMC Urology, vol. 13, article 9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. L. H. J. Looijenga, G. Zafarana, B. Grygalewicz et al., “Role of gain of 12p in germ cell tumour development,” APMIS, vol. 111, no. 1, pp. 161–170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. F. Lutke Holzik, H. J. Hoekstra, N. H. Mulder, A. J. H. Suurmeijer, D. T. Sleijfer, and J. A. Gietema, “Non-germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor,” Annals of Surgical Oncology, vol. 10, no. 2, pp. 131–135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. García-Labastida, G. S. Gómez-Macías, J. P. Flores-Gutiérrez et al., “Secondary malignant transformation of testicular teratomas: case series and literature review,” Actas Urologicas Espanolas, vol. 38, no. 9, pp. 622–627, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. O. El Mesbahi, M.-J. Terrier-Lacombe, C. Rebischung, C. Theodore, D. Vanel, and K. Fizazi, “Chemotherapy in patients with teratoma with malignant transformation,” European Urology, vol. 51, no. 5, pp. 1306–1312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Ahmed, G. J. Bosl, and S. I. Hajdu, “Teratoma with malignant transformation in germ cell tumors in men,” Cancer, vol. 56, no. 4, pp. 860–863, 1985. View at Publisher · View at Google Scholar · View at Scopus
  13. C. V. Comiter, A. S. Kibel, J. P. Richie, M. R. Nucci, and A. A. Renshaw, “Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases,” The Journal of Urology, vol. 159, no. 3, pp. 859–863, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. C. C. Guo, M. Punar, A. L. Contreras et al., “Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases,” The American Journal of Surgical Pathology, vol. 33, no. 8, pp. 1173–1178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. K. R. Rice, M. J. Magers, S. D. W. Beck et al., “Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes,” Journal of Urology, vol. 192, no. 5, pp. 1403–1409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Giannatempo, G. R. Pond, G. Sonpavde et al., “Treatment and clinical outcomes of patients with teratoma with somatic-type malignant transformation: an international collaboration,” Journal of Urology, vol. 196, pp. 95–100, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. F. C. Cabral, K. M. Krajewski, M. H. Rosenthal, M. S. Hirsch, and S. A. Howard, “Teratoma with malignant transformation: report of three cases and review of the literature,” Clinical Imaging, vol. 38, no. 5, pp. 589–593, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Fujimura, Y. Yamada, M. Nasu, K. Hamasaki, S. Minowada, and T. Kitamura, “Different transformation of mature teratoma in a patient with mixed germ cell tumor of the testis,” International Journal of Urology, vol. 12, no. 6, pp. 588–590, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A.-C. Piketty, A. Fléchon, A. Laplanche et al., “The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area,” British Journal of Cancer, vol. 93, no. 8, pp. 909–914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Honecker, D. Koychev, A. D. Luhmann et al., “Venous thromboembolic events in germ cell cancer patients undergoing platinum-based chemotherapy,” Onkologie, vol. 36, no. 11, pp. 663–668, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Solari, M. Krönig, G. Ihorst et al., “High rates of thromboembolic events in patients with germ cell cancer undergoing cisplatin-based polychemotherapy,” Urologia Internationalis, vol. 96, no. 4, pp. 399–405, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. K.-P. Dieckmann, P. Albers, J. Classen et al., “Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases,” The Journal of Urology, vol. 173, no. 3, pp. 824–829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Ehrlich, E. Rosenbaum, and J. Baniel, “Late relapse of testis cancer,” Current Urology Reports, vol. 14, no. 5, pp. 518–524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. F. K. Mostofi and L. H. Sobin, Histological Typing of Testis Tumors, World Health Organization, Geneva, Switzerland, 1977.
  25. T. M. Ulbright, P. J. Loehrer, L. M. Roth, L. H. Einhorn, S. D. Williams, and S. A. Clark, “The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases,” Cancer, vol. 54, no. 9, pp. 1824–1833, 1984. View at Publisher · View at Google Scholar · View at Scopus
  26. M. J. Magers, C.-S. Kao, C. D. Cole et al., “‘Somatic-type’ malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin,” American Journal of Surgical Pathology, vol. 38, no. 10, pp. 1396–1409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. D. Ahlgren, C. R. Simrell, T. J. Triche, R. Ozols, and S. H. Barsky, “Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy,” Cancer, vol. 54, no. 9, pp. 2015–2018, 1984. View at Publisher · View at Google Scholar · View at Scopus
  28. K. R. Rice, S. D. W. Beck, J. A. Pedrosa, T. A. Masterson, L. H. Einhorn, and R. S. Foster, “Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer,” Urology, vol. 84, no. 4, pp. 886–891, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. H. D. Malagón, A. M. C. Valdez, C. A. Moran, and S. Suster, “Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases,” American Journal of Surgical Pathology, vol. 31, no. 9, pp. 1356–1362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. J. Bosl, D. H. Ilson, E. Rodriguez, R. J. Motzer, V. E. Reuter, and R. S. K. Chaganti, “Clinical relevance of the I(12p) chromosome in germ cell tumors,” Journal of the National Cancer Institute, vol. 86, no. 5, pp. 349–355, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Summersgill, H. Goker, P. Osin et al., “Establishing germ cell origin of undifferentiated tumors by identifying gain of 12p material using comparative genomic hybridization analysis of paraffin-embedded samples,” Diagnostic Molecular Pathology, vol. 7, no. 5, pp. 260–266, 1998. View at Publisher · View at Google Scholar · View at Scopus